| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 37 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.66M | - | |
| CFO | 58.4K | $16.73M | - | |
| VP | 29.8K | $8.52M | - | |
| VP | 23.7K | $6.78M | - | |
| Dir | 23.2K | $6.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2019 | Sharp Philip A45 | Director | Sale+OE | 15,000 | $88.23 | $1,323,442.00 | -1.6% | |
| Aug 30, 2018 | Greenstreet Yvonne49 | EVP, Chief Operating Officer | Sell | 2,500 | $120.00 | $300,000.00 | -56.6% | |
| Jul 25, 2018 | Maraganore John | Chief Executive Officer | Sale+OE | 50,000 | $105.39 | $5,269,457.42 | -5.3% | |
| Jun 20, 2018 | Keating Laurie55 | SVP, GC &Secretary | Sale+OE | 1,563 | $105.04 | $164,177.52 | -9.7% | |
| May 31, 2018 | Clarke John K | Director | Sale+OE | 15,000 | $100.31 | $1,504,677.90 | -23.0% | |
| Mar 26, 2018 | Greenstreet Yvonne49 | EVP, Chief Operating Officer | Sale+OE | 7,221 | $136.54 | $985,958.28 | -67.2% | |
| Mar 20, 2018 | Keating Laurie55 | SVP, GC &Secretary | Sale+OE | 1,562 | $149.83 | $234,032.98 | -2.0% | |
| Mar 14, 2018 | Vaishnaw Akshay56 | President, R&D | Sale+OE | 88,554 | $143.10 | $12,672,126.11 | -23.1% | |
| Mar 14, 2018 | Greene Barry E | President | Sell | 38,460 | $143.10 | $5,503,735.75 | -7.6% | |
| Mar 13, 2018 | Sharp Philip A45 | Director | Sale+OE | 15,000 | $149.00 | $2,235,000.00 | -9.6% |